Most people love chocolates. Babies are no exception. Give them chocolates, and they will gobble it up in no time. However, the question remains if chocolates are safe for children. There are conflicting reports regarding chocolates. While some say that chocolates help the baby’s development, pediatric associations worldwide agree that you should not introduce chocolates to babies below the age of two. However, many nutrition drinks for babies come in the chocolate flavor. Research so far has not shown any benefits related to the consumption of chocolates and the baby’s development.
Why should you not give chocolates to babies younger than two years of age?
American Association for Pediatrics and other significant pediatric associations across the world recommend not giving babies chocolates. However, the truth is that most kids get their first taste of chocolate before the age of two. Kids love chocolates, and adults love indulging kids with different chocolates. Therefore, it is difficult to keep your child away from chocolates that they receive as treats from adults.
The reasons why you should avoid giving chocolates to your babies include:
- Chocolates have high quantities of added sugar. Kids are usually never given bitter dark chocolates. Most commercial chocolate bars contain refined sugar, preservatives, and other synthetic products that can cause health concerns.
- Chocolate contains caffeine, a potent stimulant that can affect the central nervous system of your baby. As adults, we are capable of tolerating caffeine. However, babies have a central nervous system that is still developing. Too much caffeine can disturb the development of their nervous system and make them restless and hyperactive. If a child has been diagnosed with ADHD (attention deficit hyperactivity disorder), they should be kept away from chocolates.
- Too many chocolates can also drastically increase your child's heart rate. Chocolates can increase your baby’s blood pressure and make it difficult for them to fall asleep.
- Chocolates can cause tooth decay. As chocolates contain added sugar, they can decay your child’s enamel and gums and cause cavities.
- Some babies are allergic to cocoa. As the primary ingredient in chocolate is cocoa, it can cause severe allergic reactions in your baby. Chocolate bars are also often loaded with nuts, wheat, and milk. If your child is allergic to nuts, lactose, or gluten, it is best to avoid giving them chocolates.
- If your child suffers from colic or bloating, avoid chocolates. Chocolates are acidic and can trigger acid reflux and other gastroesophageal reactions.
Should I avoid chocolates altogether?
As a parent, you may feel worried about giving chocolates to your child. However, anything in moderation is fine. Try to introduce chocolates after your child turns two. Give them a small number of chocolates as a treat only when their tummy is full. Do not give chocolates before bedtime.
Conclusion
Chocolates in small quantities are fine. Introduce your child to chocolates with milk chocolate, as it contains less caffeine. Chocolate in itself is not harmful. The added sugar in chocolates increases the risk of obesity and type 2 diabetes. Therefore, it is better to avoid eating excess chocolates.
Author Bio:
Rachitaa Singh is a freelance content writer by her profession and has over 6 years of experience into blogging and article writing. Over the years, she has gained popularity as a content creator who specialises on topics such as parenting, pregnancy and new-born childcare. However, her forte is on writing articles on baby's cord blood stem cells preservation, stem cell therapy and research.
Genetic and hematopoietic diseases are also treated with stem cells, further increasing the utility of the umbilical cord blood market to the healthcare sector.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=10547Growing government support has been crucial for the global umbilical cord blood market and is likely to remain the key driver in the coming years.
The rising presence of private players in stem cell research is also vital for the global umbilical cord blood market.Request COVID Analysis on Stem Cell Umbilical Cord Blood Market –https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=10547Stem Cell Umbilical Cord Blood Market: OverviewUmbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells.
UCB stem cells are also used to treat genetic and hematopoietic disorders.The cord blood collected during childbirth is cryopreserved and stored.
This preserved blood is generally used at the time of treatment of chronic ailments or transplantation, if needed, in the later stages of life.Governments around the world have been proactively financing campaigns to spread public awareness about the potential benefits of UCB stem cells.
It features an in-depth analysis of the key market drivers, restraints, and opportunities.
Other highlights of the report include a market attractiveness analysis, representation of prominent enterprises in the market in terms of key shares, competitive analysis, SWOT analysis, and Porter’s five forces analysis.Request Customization on Stem Cell Umbilical Cord Blood Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=10547 Stem Cell Umbilical Cord Blood Market: Key Trends and OpportunitiesUCB stem cells have emerged as an effective treatment option for over 80 diseases including immunodeficiency disorders, cancer, and other chronic blood disorders.
It is made up of two small arteries and a vein.
During pregnancy, the umbilical cord can grow up to 50 centimetres in length and 2 centimetres in diameter, almost like a spring, around the jelly encouraging the baby’s movement.
However, the coiling – pattern develops itself by the ninth week of pregnancy.
The stem cells can be harvested and cryo-preserved for future usage, thus allowing the parents-to-be to make an informed decision on cord blood banking But the cord comes with its many challenges, rather abnormalities The cord abnormalities are: Length: The cord may be too long or short.Placenta Insertion: The cord may not connect to the placenta properlyCord Compression or Knot: Nuchal cord or entanglement of the umbilical cord around the foetal neck.Reasons Behind an Umbilical Cord Knot During pregnancy, the baby, kicks and wiggles, thus exploring the home, inside your womb.
Most of these knots take place, during the pregnancy early on, while the baby is still small and has space to move around.
But there are factors too that increase the chances of cord knot like: Twins sharing one amniotic sac Not enough amniotic fluid for the baby An umbilical cord which longer than is necessary A baby, who smaller than normal, thus allowing more space to move aroundSigns of a Cord KnotDuring pregnancy, you might have to go for regular check-ups, via ultrasound scans.
Cord blood is the remaining blood in a newborn's umbilical cord and placenta.
Rather than letting the blood go to waste, you can save it in a cord blood bank.
People store cord blood because it comprises hematopoietic stem cells that can treat many types of diseases.
Read this full blog at https://bit.ly/2KlAT8W
Global Umbilical Cord Blood (UCB) Stem Cell market expansion is being boosted by the fast-rising demand income, decreasing industrialization, product recognition among consumers, emerging technological advancements market businesses, and structure that is secure.
Growth-drivers are anticipated to add notable growth into the market in the not-too-distant future.The global Umbilical Cord Blood (UCB) Stem Cell market study will help you investigate the market share and trends according to the top industry giants and help you recognize the threats and challenges the market is expected to face.
IMR Market Reports have a systemic approach for assessing the report and conducting the analysis by the authentic data provided and researched by our expert analysts.Key Player Mentioned:Advanced Cell TechnologyAthersysCalifornia Stem CellCytori TherapeuticsMesoblastOpexa TherapeuticsCaladrius BiosciencesFor Right Perspective & Competitive Insights, Request a Sample @: https://imrmarketreports.com/request/17045The study needed to concentrate on Leading manufacturers environments, and analysis for its market that is Umbilical Cord Blood (UCB) Stem Cell.
The researchers focused on development tendencies in addition to the sector.
Additionally, the marketplace is anticipated to quicken alliances which are implemented across the globe as a result of exponential need over companies and businesses.Product Segment Analysis:Stem Cell TransplantAutologous TransplantAllogenic TransplantTransplant MedicineRegenerative MedicineOthersApplication Segment Analysis:Therapeutics Service CompaniesPrivate And Government Research InstitutesAcademic InstitutesResearch Based Pharmaceutical CompaniesPublic And Private Cord Blood BanksOthersRegional Segment Analysis: North America, Europe, Asia Pacific, Latin America, and Mideast and Africa.Regional evaluation is yet another highly vast region of the research and analysis study of the Global Umbilical Cord Blood (UCB) Stem Cell Market presented in the report.
The historical and forecast period 2021 to 2027 gives accurate and detailed country-wise quantity evaluation along with region-wise market size analysis from their worldwide marketplace.Get Your Copy at a Discounted Rate!!!
